Alpha Dna Investment Management LLC Amgen Inc Transaction History

Alpha Dna Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $54,657 - $60,638	-234 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $5,769 - $6,723	26 Added 12.5%	234 $58,000
Q4 2020 Mar 24, 2021	SELL	$216.38 - $257.67 $2,812 - $3,349	-13 Reduced 5.88%	208 $47,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $47,819 - $56,945	221 New	221 $50,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Dna Investment Management LLC with notifications on news.